JP2002500923A - 人工心臓弁 - Google Patents
人工心臓弁Info
- Publication number
- JP2002500923A JP2002500923A JP2000528238A JP2000528238A JP2002500923A JP 2002500923 A JP2002500923 A JP 2002500923A JP 2000528238 A JP2000528238 A JP 2000528238A JP 2000528238 A JP2000528238 A JP 2000528238A JP 2002500923 A JP2002500923 A JP 2002500923A
- Authority
- JP
- Japan
- Prior art keywords
- leaflet
- valve body
- valve
- arcuate edge
- heart valve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003709 heart valve Anatomy 0.000 title claims abstract description 70
- 230000017531 blood circulation Effects 0.000 claims description 20
- 230000001788 irregular Effects 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 4
- 230000002093 peripheral effect Effects 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 206010018910 Haemolysis Diseases 0.000 abstract description 7
- 230000008588 hemolysis Effects 0.000 abstract description 7
- 238000011144 upstream manufacturing Methods 0.000 description 28
- 210000004369 blood Anatomy 0.000 description 18
- 239000008280 blood Substances 0.000 description 18
- 210000005069 ears Anatomy 0.000 description 16
- 239000013598 vector Substances 0.000 description 16
- 239000012528 membrane Substances 0.000 description 12
- 239000002184 metal Substances 0.000 description 12
- 238000013461 design Methods 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 208000007536 Thrombosis Diseases 0.000 description 6
- 238000010276 construction Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 230000004323 axial length Effects 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 230000007797 corrosion Effects 0.000 description 4
- 238000005260 corrosion Methods 0.000 description 4
- 230000003628 erosive effect Effects 0.000 description 4
- 229910002804 graphite Inorganic materials 0.000 description 4
- 239000010439 graphite Substances 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000009958 sewing Methods 0.000 description 4
- 238000012937 correction Methods 0.000 description 3
- 208000005189 Embolism Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000009172 bursting Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 239000002296 pyrolytic carbon Substances 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 230000001732 thrombotic effect Effects 0.000 description 2
- 101100315260 Picea mariana SB09 gene Proteins 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2403—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with pivoting rigid closure members
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/010,449 | 1998-01-22 | ||
| US09/010,449 US6096075A (en) | 1998-01-22 | 1998-01-22 | Prosthetic heart valve |
| PCT/US1999/000301 WO1999037249A1 (en) | 1998-01-22 | 1999-01-07 | Prosthetic heart valve |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002500923A true JP2002500923A (ja) | 2002-01-15 |
| JP2002500923A5 JP2002500923A5 (enExample) | 2006-02-16 |
Family
ID=21745807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000528238A Pending JP2002500923A (ja) | 1998-01-22 | 1999-01-07 | 人工心臓弁 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6096075A (enExample) |
| EP (1) | EP1049426B1 (enExample) |
| JP (1) | JP2002500923A (enExample) |
| AU (1) | AU736769B2 (enExample) |
| CA (1) | CA2318130C (enExample) |
| DE (1) | DE69930500T2 (enExample) |
| WO (1) | WO1999037249A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10182907B2 (en) | 2007-05-02 | 2019-01-22 | Novostia Sa | Mechanical prosthetic heart valve |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395024B1 (en) | 1997-05-20 | 2002-05-28 | Triflo Medical, Inc. | Mechanical heart valve |
| US6730122B1 (en) * | 2000-11-28 | 2004-05-04 | St. Jude Medical, Inc. | Prosthetic heart valve with increased lumen |
| US20040043052A1 (en) | 2002-05-24 | 2004-03-04 | Angiotech Pharmaceuticals, Inc. | Compositions and methods for coating medical implants |
| US20080086202A1 (en) * | 2002-09-27 | 2008-04-10 | Didier Lapeyre | Mechanical heart valve |
| EP1734903B2 (en) | 2004-03-11 | 2022-01-19 | Percutaneous Cardiovascular Solutions Pty Limited | Percutaneous heart valve prosthesis |
| WO2006138380A2 (en) * | 2005-06-15 | 2006-12-28 | Massachusetts Institute Of Technology | Amine-containing lipids and uses thereof |
| MX353900B (es) | 2008-11-07 | 2018-02-01 | Massachusetts Inst Technology | Lipidoides de aminoalcohol y usos de los mismos. |
| EP4321134A3 (en) | 2008-11-21 | 2024-05-01 | Percutaneous Cardiovascular Solutions Pty Limited | Heart valve prosthesis and method |
| RU2398551C1 (ru) * | 2009-02-19 | 2010-09-10 | Общество с ограниченной ответственностью "Ремонтно-механический завод Кирово-Чепецкого химического комбината" | Протез клапана сердца |
| EP3403647A1 (en) | 2009-12-01 | 2018-11-21 | Translate Bio, Inc. | Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases |
| WO2012027675A2 (en) | 2010-08-26 | 2012-03-01 | Massachusetts Institute Of Technology | Poly(beta-amino alcohols), their preparation, and uses thereof |
| US9238716B2 (en) | 2011-03-28 | 2016-01-19 | Massachusetts Institute Of Technology | Conjugated lipomers and uses thereof |
| US20140206753A1 (en) | 2011-06-08 | 2014-07-24 | Shire Human Genetic Therapies, Inc. | Lipid nanoparticle compositions and methods for mrna delivery |
| EP2859102A4 (en) | 2012-06-08 | 2016-05-11 | Shire Human Genetic Therapies | NUCLEASE RESISTANT POLYNUCLEOTIDES AND USES THEREOF |
| ES2981185T3 (es) | 2013-03-14 | 2024-10-07 | Translate Bio Inc | Métodos para la purificación de ARN mensajero |
| CA2904151C (en) | 2013-03-14 | 2023-09-12 | Shire Human Genetic Therapies, Inc. | Cftr mrna compositions and related methods and uses |
| WO2014179562A1 (en) | 2013-05-01 | 2014-11-06 | Massachusetts Institute Of Technology | 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof |
| WO2015061491A1 (en) | 2013-10-22 | 2015-04-30 | Shire Human Genetic Therapies, Inc. | Mrna therapy for phenylketonuria |
| BR112016009014B1 (pt) | 2013-10-22 | 2024-02-06 | Translate Bio, Inc | USO DE COMPOSIÇÃO COMPREENDENDO mRNA PARA DEFICIÊNCIA DE ARGININOSSUCINATO SINTETASE |
| MX2016005238A (es) | 2013-10-22 | 2016-08-12 | Shire Human Genetic Therapies | Formulaciones de lipidos para la administracion de acido ribonucleico mensajero. |
| MX373952B (es) | 2014-04-25 | 2020-07-13 | Shire Human Genetic Therapies | Métodos de purificación de arn mensajero. |
| CN106659731A (zh) | 2014-05-30 | 2017-05-10 | 夏尔人类遗传性治疗公司 | 用于递送核酸的可生物降解脂质 |
| UA121863C2 (uk) | 2014-06-24 | 2020-08-10 | Транслейт Байо, Інк. | Стереохімічно збагачені композиції для доставки нуклеїнових кислот |
| US9840479B2 (en) | 2014-07-02 | 2017-12-12 | Massachusetts Institute Of Technology | Polyamine-fatty acid derived lipidoids and uses thereof |
| MX2019010155A (es) | 2017-02-27 | 2020-12-10 | Translate Bio Inc | Arnm de cftr optimizado por codón novedoso. |
| MA49138A (fr) | 2017-05-16 | 2020-03-25 | Translate Bio Inc | Traitement de la fibrose kystique par administration d'arnm à codons optimisés codant pour la cftr |
| WO2020041793A1 (en) | 2018-08-24 | 2020-02-27 | Translate Bio, Inc. | Methods for purification of messenger rna |
| AU2019384557B2 (en) | 2018-11-21 | 2025-07-17 | Translate Bio, Inc. | Treatment of cystic fibrosis by delivery of nebulized mRNA encoding CFTR |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4078268A (en) * | 1975-04-24 | 1978-03-14 | St. Jude Medical, Inc. | Heart valve prosthesis |
| US4276658A (en) * | 1977-11-02 | 1981-07-07 | St. Jude Medical, Inc. | Heart valve prosthesis |
| US4451937A (en) * | 1982-02-08 | 1984-06-05 | Hemex, Inc. | Heart valve having ear guided occluders |
| US4689046A (en) * | 1985-03-11 | 1987-08-25 | Carbomedics, Inc. | Heart valve prosthesis |
| US5123920A (en) * | 1990-06-13 | 1992-06-23 | Onx, Inc. | Prosthetic heart valve |
| FR2655843A1 (fr) * | 1989-12-20 | 1991-06-21 | Commissariat Energie Atomique | Valve cardiaque a clapets pivotant sur des billes. |
| RU1767723C (ru) * | 1990-08-14 | 1995-01-27 | Кирово-Чепецкий химический комбинат | Протез клапана сердца |
| US5152785A (en) * | 1991-03-25 | 1992-10-06 | Onx, Inc. | Prosthetic heart valve |
| AU2346992A (en) * | 1991-06-06 | 1993-01-08 | Medtronic, Inc. | Composite curvature bileaflet prosthetic heart valve |
| US5354330A (en) * | 1991-10-31 | 1994-10-11 | Ats Medical Inc. | Heart valve prosthesis |
| US5376111A (en) * | 1992-07-24 | 1994-12-27 | Onx, Inc. | Heart valve prostheses |
| AU5437396A (en) * | 1995-03-29 | 1996-10-16 | Cv Dynamics, Inc. Dba Medical Incorporated | Bileaflet heart valve |
| US5641324A (en) * | 1995-05-16 | 1997-06-24 | Medical Carbon Research Institute, Llc | Prosthetic heart valve |
| WO1997005834A1 (en) * | 1995-08-07 | 1997-02-20 | Baxter International Inc. | Bileaflet mechanical heart valve having arrowhead slot hinge configuration |
-
1998
- 1998-01-22 US US09/010,449 patent/US6096075A/en not_active Expired - Lifetime
-
1999
- 1999-01-07 CA CA002318130A patent/CA2318130C/en not_active Expired - Lifetime
- 1999-01-07 JP JP2000528238A patent/JP2002500923A/ja active Pending
- 1999-01-07 AU AU22153/99A patent/AU736769B2/en not_active Expired
- 1999-01-07 EP EP99902094A patent/EP1049426B1/en not_active Expired - Lifetime
- 1999-01-07 DE DE69930500T patent/DE69930500T2/de not_active Expired - Lifetime
- 1999-01-07 WO PCT/US1999/000301 patent/WO1999037249A1/en not_active Ceased
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10182907B2 (en) | 2007-05-02 | 2019-01-22 | Novostia Sa | Mechanical prosthetic heart valve |
Also Published As
| Publication number | Publication date |
|---|---|
| AU736769B2 (en) | 2001-08-02 |
| US6096075A (en) | 2000-08-01 |
| AU2215399A (en) | 1999-08-09 |
| EP1049426A1 (en) | 2000-11-08 |
| EP1049426B1 (en) | 2006-03-22 |
| CA2318130C (en) | 2007-04-10 |
| CA2318130A1 (en) | 1999-07-29 |
| WO1999037249A1 (en) | 1999-07-29 |
| DE69930500D1 (de) | 2006-05-11 |
| DE69930500T2 (de) | 2006-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002500923A (ja) | 人工心臓弁 | |
| AU701949B2 (en) | Prosthetic heart valve | |
| US5314467A (en) | Composite curvature bileaflet prosthetic heart valve with serpentine curve hinge recesses | |
| US5908452A (en) | Prosthetic heart valve with improved blood flow | |
| US5522886A (en) | Heart valve prostheses | |
| WO1999026560A1 (en) | Prosthetic heart valve | |
| US4357715A (en) | Heart valve prosthesis | |
| EP0023797A1 (en) | Heart valve prosthesis | |
| JPH0214053B2 (enExample) | ||
| AU660668B2 (en) | Improved prosthetic heart valve | |
| US5152785A (en) | Prosthetic heart valve | |
| US5545216A (en) | Prosthetic heart valve | |
| WO1991001698A1 (en) | Prosthetic heart valve | |
| US5080669A (en) | Prosthetic heart valve | |
| US5123920A (en) | Prosthetic heart valve | |
| US4021863A (en) | Heart valve prosthesis | |
| CN115209840A (zh) | 机械人工心脏瓣膜 | |
| US5192313A (en) | Heart valve prosthesis with improved bi-leaflet pivot design | |
| CN115209841A (zh) | 机械人工心脏瓣膜 | |
| US5246453A (en) | Prosthetic heart valve | |
| US5741328A (en) | Pivot for mechanical heart valve prothesis | |
| US4319364A (en) | Pivoting disc heart valve | |
| CA2218621C (en) | Prosthetic heart valve | |
| US5308361A (en) | Prosthetic heart valve | |
| EP0037768B1 (en) | Pivoting disc heart valve |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20040916 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20040916 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20040916 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051216 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20051216 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080715 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20081226 |